nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—NTSR2—medulla oblongata—multiple sclerosis	0.0616	0.174	CbGeAlD
Levocabastine—NTSR2—midbrain—multiple sclerosis	0.0563	0.159	CbGeAlD
Levocabastine—NTSR2—spinal cord—multiple sclerosis	0.0549	0.155	CbGeAlD
Levocabastine—NTSR2—nervous system—multiple sclerosis	0.0463	0.131	CbGeAlD
Levocabastine—NTSR2—central nervous system—multiple sclerosis	0.0446	0.126	CbGeAlD
Levocabastine—NTSR2—cerebellum—multiple sclerosis	0.0436	0.123	CbGeAlD
Levocabastine—NTSR2—brain—multiple sclerosis	0.0354	0.0999	CbGeAlD
Levocabastine—NTSR2—Peptide GPCRs—CCR1—multiple sclerosis	0.0236	0.0476	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CXCR3—multiple sclerosis	0.0157	0.0315	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CCR2—multiple sclerosis	0.0152	0.0307	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—GPR65—multiple sclerosis	0.0123	0.0248	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.0111	0.0224	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.0111	0.0224	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.011	0.0222	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.0101	0.0204	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CCR5—multiple sclerosis	0.00982	0.0198	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00952	0.0192	CbGpPWpGaD
Levocabastine—Eye pain—Fingolimod—multiple sclerosis	0.00879	0.059	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.0087	0.0175	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00815	0.0164	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00792	0.0159	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—S1PR1—multiple sclerosis	0.0077	0.0155	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00746	0.015	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00746	0.015	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00737	0.0148	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00716	0.0144	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—GPR65—multiple sclerosis	0.00621	0.0125	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00597	0.012	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00595	0.012	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00577	0.0116	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL13—multiple sclerosis	0.00568	0.0114	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCR1—multiple sclerosis	0.00568	0.0114	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00561	0.0113	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—IL4R—multiple sclerosis	0.00543	0.0109	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00531	0.0107	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00518	0.0104	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00512	0.0103	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00512	0.0103	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00494	0.00994	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00481	0.00967	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00462	0.00929	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00444	0.00893	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00435	0.00876	CbGpPWpGaD
Levocabastine—HRH1—nervous system—multiple sclerosis	0.00419	0.0118	CbGeAlD
Levocabastine—Cough—Fingolimod—multiple sclerosis	0.00417	0.028	CcSEcCtD
Levocabastine—Stinging—Prednisolone—multiple sclerosis	0.00412	0.0277	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL3—multiple sclerosis	0.00405	0.00814	CbGpPWpGaD
Levocabastine—HRH1—central nervous system—multiple sclerosis	0.00403	0.0114	CbGeAlD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00399	0.00804	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00395	0.00796	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—PTGER4—multiple sclerosis	0.0039	0.00784	CbGpPWpGaD
Levocabastine—Stinging—Triamcinolone—multiple sclerosis	0.00379	0.0254	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCR3—multiple sclerosis	0.00376	0.00757	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—RGS1—multiple sclerosis	0.0037	0.00745	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCR2—multiple sclerosis	0.00366	0.00737	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00361	0.00728	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00361	0.00726	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00353	0.00711	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00351	0.00706	CbGpPWpGaD
Levocabastine—Dyspnoea—Fingolimod—multiple sclerosis	0.00348	0.0233	CcSEcCtD
Levocabastine—Stinging—Dexamethasone—multiple sclerosis	0.00344	0.0231	CcSEcCtD
Levocabastine—Stinging—Betamethasone—multiple sclerosis	0.00344	0.0231	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00344	0.00692	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CNR1—multiple sclerosis	0.00338	0.0068	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—RGS1—multiple sclerosis	0.00336	0.00677	CbGpPWpGaD
Levocabastine—Fatigue—Fingolimod—multiple sclerosis	0.00336	0.0226	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00321	0.00646	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00321	0.00646	CbGpPWpGaD
Levocabastine—HRH1—brain—multiple sclerosis	0.0032	0.00903	CbGeAlD
Levocabastine—NTSR2—Signaling by GPCR—GPR65—multiple sclerosis	0.00319	0.00641	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.0031	0.00623	CbGpPWpGaD
Levocabastine—Pharyngitis—Cladribine—multiple sclerosis	0.00309	0.0207	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—LINGO1—multiple sclerosis	0.00308	0.0062	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00304	0.00612	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR1—multiple sclerosis	0.00291	0.00587	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00291	0.00587	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.0029	0.00584	CbGpPWpGaD
Levocabastine—Asthenia—Fingolimod—multiple sclerosis	0.0028	0.0188	CcSEcCtD
Levocabastine—Erythema—Cladribine—multiple sclerosis	0.00271	0.0182	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—TAGAP—multiple sclerosis	0.00267	0.00538	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL5—multiple sclerosis	0.00262	0.00527	CbGpPWpGaD
Levocabastine—Visual disturbance—Prednisolone—multiple sclerosis	0.00256	0.0172	CcSEcCtD
Levocabastine—Headache—Fingolimod—multiple sclerosis	0.00244	0.0164	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00242	0.00487	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00237	0.00477	CbGpPWpGaD
Levocabastine—Cough—Cladribine—multiple sclerosis	0.00236	0.0159	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCR5—multiple sclerosis	0.00236	0.00475	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—S1PR1—multiple sclerosis	0.00234	0.0047	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GPC5—multiple sclerosis	0.00227	0.00457	CbGpPWpGaD
Levocabastine—Eye pain—Dexamethasone—multiple sclerosis	0.00224	0.015	CcSEcCtD
Levocabastine—Eye pain—Betamethasone—multiple sclerosis	0.00224	0.015	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0022	0.00443	CbGpPWpGaD
Levocabastine—Visual disturbance—Dexamethasone—multiple sclerosis	0.00214	0.0143	CcSEcCtD
Levocabastine—Visual disturbance—Betamethasone—multiple sclerosis	0.00214	0.0143	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00213	0.00428	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL3—multiple sclerosis	0.00208	0.00418	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00207	0.00416	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—IL4—multiple sclerosis	0.00206	0.00415	CbGpPWpGaD
Levocabastine—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00203	0.0136	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.002	0.00402	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—RGS1—multiple sclerosis	0.00199	0.004	CbGpPWpGaD
Levocabastine—Dyspnoea—Cladribine—multiple sclerosis	0.00197	0.0132	CcSEcCtD
Levocabastine—Somnolence—Cladribine—multiple sclerosis	0.00196	0.0132	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00193	0.00389	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00191	0.00384	CbGpPWpGaD
Levocabastine—Fatigue—Cladribine—multiple sclerosis	0.00191	0.0128	CcSEcCtD
Levocabastine—Pain—Cladribine—multiple sclerosis	0.00189	0.0127	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—GPR65—multiple sclerosis	0.00188	0.00379	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR2—multiple sclerosis	0.00188	0.00378	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00187	0.00376	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00185	0.00372	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—POMC—multiple sclerosis	0.00184	0.00371	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL2—multiple sclerosis	0.0018	0.00363	CbGpPWpGaD
Levocabastine—Erythema—Mitoxantrone—multiple sclerosis	0.00178	0.0119	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CNR1—multiple sclerosis	0.00173	0.00349	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL13—multiple sclerosis	0.00172	0.00347	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR1—multiple sclerosis	0.00172	0.00347	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00172	0.00346	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00167	0.00336	CbGpPWpGaD
Levocabastine—Visual impairment—Prednisolone—multiple sclerosis	0.00162	0.0108	CcSEcCtD
Levocabastine—Asthenia—Cladribine—multiple sclerosis	0.00159	0.0106	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00156	0.00314	CbGpPWpGaD
Levocabastine—Visual disturbance—Methotrexate—multiple sclerosis	0.00155	0.0104	CcSEcCtD
Levocabastine—Cough—Mitoxantrone—multiple sclerosis	0.00155	0.0104	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00153	0.00309	CbGpPWpGaD
Levocabastine—Pharyngitis—Triamcinolone—multiple sclerosis	0.00153	0.0103	CcSEcCtD
Levocabastine—Visual impairment—Methylprednisolone—multiple sclerosis	0.00148	0.00995	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00148	0.00298	CbGpPWpGaD
Levocabastine—Erythema—Prednisolone—multiple sclerosis	0.00146	0.0098	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00144	0.00291	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00142	0.00286	CbGpPWpGaD
Levocabastine—Rash—Cladribine—multiple sclerosis	0.00139	0.00935	CcSEcCtD
Levocabastine—Dermatitis—Cladribine—multiple sclerosis	0.00139	0.00934	CcSEcCtD
Levocabastine—Headache—Cladribine—multiple sclerosis	0.00138	0.00929	CcSEcCtD
Levocabastine—Visual impairment—Dexamethasone—multiple sclerosis	0.00135	0.00905	CcSEcCtD
Levocabastine—Visual impairment—Betamethasone—multiple sclerosis	0.00135	0.00905	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL5—multiple sclerosis	0.00134	0.0027	CbGpPWpGaD
Levocabastine—Erythema—Triamcinolone—multiple sclerosis	0.00134	0.00901	CcSEcCtD
Levocabastine—Erythema—Methylprednisolone—multiple sclerosis	0.00134	0.00899	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.00133	0.00268	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	0.00133	0.00268	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00132	0.00266	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00131	0.00264	CbGpPWpGaD
Levocabastine—Nausea—Cladribine—multiple sclerosis	0.00131	0.00881	CcSEcCtD
Levocabastine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.0013	0.00869	CcSEcCtD
Levocabastine—Somnolence—Mitoxantrone—multiple sclerosis	0.00129	0.00867	CcSEcCtD
Levocabastine—Fatigue—Mitoxantrone—multiple sclerosis	0.00125	0.0084	CcSEcCtD
Levocabastine—Pain—Mitoxantrone—multiple sclerosis	0.00124	0.00834	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00124	0.00249	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL3—multiple sclerosis	0.00123	0.00247	CbGpPWpGaD
Levocabastine—Erythema—Dexamethasone—multiple sclerosis	0.00122	0.00818	CcSEcCtD
Levocabastine—Erythema—Betamethasone—multiple sclerosis	0.00122	0.00818	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCR5—multiple sclerosis	0.00121	0.00244	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00119	0.0024	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTGER4—multiple sclerosis	0.00118	0.00238	CbGpPWpGaD
Levocabastine—Cough—Triamcinolone—multiple sclerosis	0.00117	0.00786	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00117	0.00235	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PGR—multiple sclerosis	0.00116	0.00234	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCR3—multiple sclerosis	0.00114	0.0023	CbGpPWpGaD
Levocabastine—Rash—Azathioprine—multiple sclerosis	0.00113	0.0076	CcSEcCtD
Levocabastine—Dermatitis—Azathioprine—multiple sclerosis	0.00113	0.0076	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00113	0.00228	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00113	0.00228	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CD28—multiple sclerosis	0.00113	0.00227	CbGpPWpGaD
Levocabastine—Headache—Azathioprine—multiple sclerosis	0.00113	0.00755	CcSEcCtD
Levocabastine—Dry mouth—Triamcinolone—multiple sclerosis	0.00112	0.0075	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCR2—multiple sclerosis	0.00111	0.00223	CbGpPWpGaD
Levocabastine—Nausea—Azathioprine—multiple sclerosis	0.00107	0.00716	CcSEcCtD
Levocabastine—Erythema—Prednisone—multiple sclerosis	0.00106	0.00712	CcSEcCtD
Levocabastine—Asthenia—Mitoxantrone—multiple sclerosis	0.00104	0.00699	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—POMC—multiple sclerosis	0.00104	0.0021	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CNR1—multiple sclerosis	0.00102	0.00206	CbGpPWpGaD
Levocabastine—Pain—Prednisolone—multiple sclerosis	0.00102	0.00684	CcSEcCtD
Levocabastine—Pharyngitis—Methotrexate—multiple sclerosis	0.00101	0.00678	CcSEcCtD
Levocabastine—Visual impairment—Methotrexate—multiple sclerosis	0.000982	0.00659	CcSEcCtD
Levocabastine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000977	0.00656	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—POMC—multiple sclerosis	0.000946	0.0019	CbGpPWpGaD
Levocabastine—Fatigue—Triamcinolone—multiple sclerosis	0.000945	0.00634	CcSEcCtD
Levocabastine—Fatigue—Methylprednisolone—multiple sclerosis	0.000943	0.00633	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	0.000942	0.0019	CbGpPWpGaD
Levocabastine—Pain—Triamcinolone—multiple sclerosis	0.000937	0.00629	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	0.000932	0.00187	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000925	0.00186	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000922	0.00186	CbGpPWpGaD
Levocabastine—Rash—Mitoxantrone—multiple sclerosis	0.000916	0.00615	CcSEcCtD
Levocabastine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000915	0.00614	CcSEcCtD
Levocabastine—Headache—Mitoxantrone—multiple sclerosis	0.00091	0.00611	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000906	0.00182	CbGpPWpGaD
Levocabastine—Erythema—Methotrexate—multiple sclerosis	0.000887	0.00595	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000875	0.00176	CbGpPWpGaD
Levocabastine—Nausea—Mitoxantrone—multiple sclerosis	0.000863	0.00579	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	0.000861	0.00173	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000861	0.00173	CbGpPWpGaD
Levocabastine—Fatigue—Dexamethasone—multiple sclerosis	0.000857	0.00575	CcSEcCtD
Levocabastine—Fatigue—Betamethasone—multiple sclerosis	0.000857	0.00575	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000851	0.00171	CbGpPWpGaD
Levocabastine—Pain—Dexamethasone—multiple sclerosis	0.00085	0.00571	CcSEcCtD
Levocabastine—Pain—Betamethasone—multiple sclerosis	0.00085	0.00571	CcSEcCtD
Levocabastine—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.000847	0.0017	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—TYK2—multiple sclerosis	0.00084	0.00169	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CD86—multiple sclerosis	0.000806	0.00162	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000806	0.00162	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL5—multiple sclerosis	0.000794	0.0016	CbGpPWpGaD
Levocabastine—Asthenia—Triamcinolone—multiple sclerosis	0.000786	0.00528	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000785	0.00158	CbGpPWpGaD
Levocabastine—Asthenia—Methylprednisolone—multiple sclerosis	0.000785	0.00526	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000776	0.00156	CbGpPWpGaD
Levocabastine—Cough—Methotrexate—multiple sclerosis	0.000774	0.00519	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—multiple sclerosis	0.00077	0.00155	CbGpPWpGaD
Levocabastine—Rash—Prednisolone—multiple sclerosis	0.000751	0.00504	CcSEcCtD
Levocabastine—Dermatitis—Prednisolone—multiple sclerosis	0.000751	0.00504	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000749	0.00151	CbGpPWpGaD
Levocabastine—Fatigue—Prednisone—multiple sclerosis	0.000747	0.00501	CcSEcCtD
Levocabastine—Headache—Prednisolone—multiple sclerosis	0.000747	0.00501	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—SPP1—multiple sclerosis	0.000735	0.00148	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000729	0.00147	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR5—multiple sclerosis	0.000715	0.00144	CbGpPWpGaD
Levocabastine—Asthenia—Dexamethasone—multiple sclerosis	0.000713	0.00479	CcSEcCtD
Levocabastine—Asthenia—Betamethasone—multiple sclerosis	0.000713	0.00479	CcSEcCtD
Levocabastine—Nausea—Prednisolone—multiple sclerosis	0.000708	0.00475	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000705	0.00142	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—multiple sclerosis	0.000699	0.00141	CbGpPWpGaD
Levocabastine—Rash—Triamcinolone—multiple sclerosis	0.000691	0.00464	CcSEcCtD
Levocabastine—Dermatitis—Triamcinolone—multiple sclerosis	0.00069	0.00463	CcSEcCtD
Levocabastine—Rash—Methylprednisolone—multiple sclerosis	0.000689	0.00463	CcSEcCtD
Levocabastine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000689	0.00462	CcSEcCtD
Levocabastine—Headache—Triamcinolone—multiple sclerosis	0.000687	0.00461	CcSEcCtD
Levocabastine—Headache—Methylprednisolone—multiple sclerosis	0.000685	0.0046	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000673	0.00135	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00066	0.00133	CbGpPWpGaD
Levocabastine—Nausea—Triamcinolone—multiple sclerosis	0.000651	0.00437	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—APOE—multiple sclerosis	0.00065	0.00131	CbGpPWpGaD
Levocabastine—Nausea—Methylprednisolone—multiple sclerosis	0.00065	0.00436	CcSEcCtD
Levocabastine—Dyspnoea—Methotrexate—multiple sclerosis	0.000645	0.00433	CcSEcCtD
Levocabastine—Somnolence—Methotrexate—multiple sclerosis	0.000643	0.00432	CcSEcCtD
Levocabastine—Rash—Dexamethasone—multiple sclerosis	0.000627	0.00421	CcSEcCtD
Levocabastine—Rash—Betamethasone—multiple sclerosis	0.000627	0.00421	CcSEcCtD
Levocabastine—Dermatitis—Betamethasone—multiple sclerosis	0.000626	0.0042	CcSEcCtD
Levocabastine—Dermatitis—Dexamethasone—multiple sclerosis	0.000626	0.0042	CcSEcCtD
Levocabastine—Fatigue—Methotrexate—multiple sclerosis	0.000624	0.00419	CcSEcCtD
Levocabastine—Headache—Dexamethasone—multiple sclerosis	0.000623	0.00418	CcSEcCtD
Levocabastine—Headache—Betamethasone—multiple sclerosis	0.000623	0.00418	CcSEcCtD
Levocabastine—Asthenia—Prednisone—multiple sclerosis	0.000621	0.00417	CcSEcCtD
Levocabastine—Pain—Methotrexate—multiple sclerosis	0.000619	0.00415	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	0.000614	0.00124	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000606	0.00122	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	0.0006	0.00121	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000591	0.00119	CbGpPWpGaD
Levocabastine—Nausea—Dexamethasone—multiple sclerosis	0.000591	0.00396	CcSEcCtD
Levocabastine—Nausea—Betamethasone—multiple sclerosis	0.000591	0.00396	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CD80—multiple sclerosis	0.000588	0.00118	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000571	0.00115	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000561	0.00113	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—POMC—multiple sclerosis	0.000559	0.00112	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	0.000555	0.00112	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000548	0.0011	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL2—multiple sclerosis	0.000547	0.0011	CbGpPWpGaD
Levocabastine—Rash—Prednisone—multiple sclerosis	0.000546	0.00366	CcSEcCtD
Levocabastine—Dermatitis—Prednisone—multiple sclerosis	0.000546	0.00366	CcSEcCtD
Levocabastine—Headache—Prednisone—multiple sclerosis	0.000543	0.00364	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000535	0.00108	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000532	0.00107	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000521	0.00105	CbGpPWpGaD
Levocabastine—Asthenia—Methotrexate—multiple sclerosis	0.000519	0.00348	CcSEcCtD
Levocabastine—Nausea—Prednisone—multiple sclerosis	0.000514	0.00345	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	0.000512	0.00103	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	0.00051	0.00103	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TYK2—multiple sclerosis	0.000496	0.000999	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000487	0.00098	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000487	0.00098	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	0.000483	0.000973	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00047	0.000945	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	0.000467	0.000941	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000461	0.000928	CbGpPWpGaD
Levocabastine—Rash—Methotrexate—multiple sclerosis	0.000456	0.00306	CcSEcCtD
Levocabastine—Dermatitis—Methotrexate—multiple sclerosis	0.000456	0.00306	CcSEcCtD
Levocabastine—Headache—Methotrexate—multiple sclerosis	0.000453	0.00304	CcSEcCtD
Levocabastine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	0.000442	0.00089	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000442	0.00089	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00044	0.000887	CbGpPWpGaD
Levocabastine—Nausea—Methotrexate—multiple sclerosis	0.00043	0.00288	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—IL2—multiple sclerosis	0.000413	0.000831	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—multiple sclerosis	0.000411	0.000827	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	0.000405	0.000816	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	0.000397	0.000799	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—multiple sclerosis	0.000391	0.000787	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000367	0.000739	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000359	0.000723	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	0.000358	0.00072	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	0.000354	0.000713	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—multiple sclerosis	0.000348	0.0007	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	0.000345	0.000694	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000334	0.000672	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—multiple sclerosis	0.000323	0.00065	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000322	0.000649	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—multiple sclerosis	0.000322	0.000649	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAPK1—multiple sclerosis	0.000316	0.000636	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	0.000315	0.000634	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000314	0.000631	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000303	0.00061	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	0.000301	0.000606	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000293	0.000589	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00029	0.000583	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	0.000286	0.000575	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	0.000285	0.000573	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00028	0.000564	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	0.00028	0.000563	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	0.000274	0.000551	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	0.000263	0.000529	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	0.000261	0.000526	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	0.000261	0.000526	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000261	0.000525	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—multiple sclerosis	0.000243	0.000489	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000237	0.000476	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000224	0.000452	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000215	0.000434	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	0.000204	0.00041	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000202	0.000407	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000199	0.000401	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	0.000186	0.000375	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	0.000184	0.000369	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000181	0.000364	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	0.000179	0.000361	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PGR—multiple sclerosis	0.000176	0.000355	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	0.000173	0.000348	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CD28—multiple sclerosis	0.000171	0.000345	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	0.000168	0.000339	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	0.000158	0.000318	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	0.000155	0.000313	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	0.000143	0.000289	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	0.00014	0.000283	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	0.00014	0.000281	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	0.000127	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CD86—multiple sclerosis	0.000122	0.000246	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	0.00012	0.000242	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	0.000117	0.000235	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	0.000111	0.000224	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	0.000108	0.000218	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	0.000107	0.000215	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	0.000106	0.000213	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOE—multiple sclerosis	9.87e-05	0.000199	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CD80—multiple sclerosis	8.92e-05	0.00018	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—POMC—multiple sclerosis	8.48e-05	0.000171	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	8.29e-05	0.000167	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.11e-05	0.000163	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	7.53e-05	0.000152	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.27e-05	0.000126	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.23e-05	0.000125	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.93e-05	0.000119	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.27e-05	0.000106	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.9e-05	9.86e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.89e-05	9.84e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.79e-05	9.65e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.68e-05	7.41e-05	CbGpPWpGaD
